| Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability J Bonaventura, S Lam, M Carlton, MA Boehm, JL Gomez, O Solís, ... Molecular psychiatry 26 (11), 6704-6722, 2021 | 161 | 2021 |
| High-potency ligands for DREADD imaging and activation in rodents and monkeys J Bonaventura, MAG Eldridge, F Hu, JL Gomez, M Sanchez-Soto, ... Nature communications 10 (1), 4627, 2019 | 145 | 2019 |
| Functional selectivity of allosteric interactions within G protein–coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer X Guitart, G Navarro, E Moreno, H Yano, NS Cai, M Sánchez-Soto, ... Molecular pharmacology 86 (4), 417-429, 2014 | 138 | 2014 |
| l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus J Bonaventura, AJ Rico, E Moreno, S Sierra, M Sánchez, N Luquin, ... Neuropharmacology 79, 90-100, 2014 | 102 | 2014 |
| l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies A Pinna, J Bonaventura, D Farré, M Sánchez, N Simola, J Mallol, C Lluís, ... Experimental neurology 253, 180-191, 2014 | 98 | 2014 |
| Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist M Sánchez-Soto, A Bonifazi, NS Cai, MP Ellenberger, AH Newman, ... Molecular pharmacology 89 (4), 457-466, 2016 | 72 | 2016 |
| Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors D Aslanoglou, S Bertera, M Sánchez-Soto, R Benjamin Free, J Lee, ... Translational psychiatry 11 (1), 59, 2021 | 64 | 2021 |
| Control of glutamate release by complexes of adenosine and cannabinoid receptors A Köfalvi, E Moreno, A Cordomí, NS Cai, V Fernández-Dueñas, ... BMC biology 18, 1-21, 2020 | 57 | 2020 |
| Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens X Guitart, E Moreno, W Rea, M Sánchez-Soto, NS Cai, C Quiroz, V Kumar, ... Molecular neurobiology 56, 6756-6769, 2019 | 40 | 2019 |
| Identification of positive allosteric modulators of the D1 dopamine receptor that act at diverse binding sites KD Luderman, JL Conroy, RB Free, N Southall, M Ferrer, M Sanchez-Soto, ... Molecular Pharmacology 94 (4), 1197-1209, 2018 | 38 | 2018 |
| A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity M Sanchez-Soto, RK Verma, BKA Willette, EC Gonye, AM Moore, ... Science signaling 13 (617), eaaw5885, 2020 | 35 | 2020 |
| α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands M Sánchez-Soto, V Casadó-Anguera, H Yano, BJ Bender, NS Cai, ... Molecular neurobiology 55, 8438-8454, 2018 | 28 | 2018 |
| Target deconvolution studies of (2R, 6R)-hydroxynorketamine: an elusive search J Bonaventura, JL Gomez, ML Carlton, S Lam, M Sanchez-Soto, PJ Morris, ... Molecular psychiatry 27 (10), 4144-4156, 2022 | 21 | 2022 |
| Pharmacological characterization of the imipridone anticancer drug ONC201 reveals a negative allosteric mechanism of action at the D2 dopamine receptor RB Free, CA Cuoco, B Xie, Y Namkung, VV Prabhu, BKA Willette, ... Molecular Pharmacology 100 (4), 372-387, 2021 | 19 | 2021 |
| Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant M Sánchez-Soto, H Yano, NS Cai, V Casadó-Anguera, E Moreno, ... Molecular neurobiology 56, 4778-4785, 2019 | 17 | 2019 |
| Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse … E Pauls, S Bayod, L Mateo, V Alcalde, T Juan-Blanco, M Sánchez-Soto, ... Genome Medicine 13, 1-23, 2021 | 12 | 2021 |
| Chemogenetic ligands for translational neurotheranostics J Bonaventura, MA Eldridge, F Hu, JL Gomez, M Sanchez-Soto, ... bioRxiv, 487637, 2018 | 12 | 2018 |
| Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants S Ferré, AM Belcher, J Bonaventura, C Quiroz, M Sánchez-Soto, ... Frontiers in Endocrinology 13, 1014678, 2022 | 11 | 2022 |
| A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus V Mammoli, A Bonifazi, D Dal Ben, M Giannella, G Giorgioni, A Piergentili, ... ChemMedChem 11 (16), 1819-1828, 2016 | 7 | 2016 |
| Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine D Aslanoglou, S Bertera, L Friggeri, M Sánchez-Soto, J Lee, X Xue, ... Iscience 25 (8), 2022 | 6 | 2022 |
